BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 30481277)

  • 1. Sex Effects on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
    Tellefsen S; Morthen MK; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5599-5614. PubMed ID: 30481277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone Influence on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome.
    Morthen MK; Tellefsen S; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2181-2197. PubMed ID: 31108549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice.
    Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome.
    Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA
    Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Akpek EK; Jabs DA; Gérard HC; Prendergast RA; Hudson AP; Lee B; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2004 Jan; 45(1):185-90. PubMed ID: 14691172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjögren's syndrome.
    Zoukhri D; Hodges RR; Dartt DA
    Clin Immunol Immunopathol; 1998 Nov; 89(2):126-33. PubMed ID: 9787114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome.
    Zoukhri D; Kublin CL
    Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice.
    Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME
    Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender- and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice.
    Toda I; Sullivan BD; Wickham LA; Sullivan DA
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):49-61. PubMed ID: 10619357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I Interferon Signaling Is Required for Dacryoadenitis in the Nonobese Diabetic Mouse Model of Sjögren Syndrome.
    Chaly Y; Barr JY; Sullivan DA; Thomas HE; Brodnicki TC; Lieberman SM
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
    Toda I; Wickham LA; Sullivan DA
    Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 versus Th2 immune responses in autoimmune lacrimal gland disease in MRL/Mp mice.
    Jabs DA; Lee B; Whittum-Hudson JA; Prendergast RA
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):826-31. PubMed ID: 10711700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome.
    Aluri HS; Kublin CL; Thotakura S; Armaos H; Samizadeh M; Hawley D; Thomas WM; Leavis P; Makarenkova HP; Zoukhri D
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5218-28. PubMed ID: 26244298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome.
    Sullivan DA; Edwards JA
    J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway.
    Ma X; Zou J; He L; Zhang Y
    Diagn Pathol; 2014 Jan; 9():5. PubMed ID: 24443980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Prendergast RA; Rorer EM; Hudson AP; Whittum-Hudson JA
    Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2567-71. PubMed ID: 11581200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoepithelial cell-driven acini contraction in response to oxytocin receptor stimulation is impaired in lacrimal glands of Sjögren's syndrome animal models.
    Hawley D; Tang X; Zyrianova T; Shah M; Janga S; Letourneau A; Schicht M; Paulsen F; Hamm-Alvarez S; Makarenkova HP; Zoukhri D
    Sci Rep; 2018 Jul; 8(1):9919. PubMed ID: 29967327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal and Sjogren's syndrome models of the murine lacrimal gland studied at single-cell resolution.
    Rattner A; Heng JS; Winer BL; Goff LA; Nathans J
    Proc Natl Acad Sci U S A; 2023 Oct; 120(42):e2311983120. PubMed ID: 37812717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sjögren's syndrome-like autoimmune sialadenitis in MRL-Faslpr mice is associated with expression of glucocorticoid-induced TNF receptor-related protein (GITR) ligand and 4-1BB ligand.
    Saito K; Mori S; Date F; Ono M
    Autoimmunity; 2013 Jun; 46(4):231-7. PubMed ID: 23301790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.